BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Up 60.0% in November

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 1,600 shares, a growth of 60.0% from the October 31st total of 1,000 shares. Based on an average daily volume of 8,300 shares, the days-to-cover ratio is currently 0.2 days.

BioNxt Solutions Stock Down 9.2 %

BioNxt Solutions stock traded down $0.02 during trading hours on Friday, hitting $0.18. The company had a trading volume of 2,300 shares, compared to its average volume of 14,040. The firm has a 50-day moving average of $0.18 and a 200 day moving average of $0.20. BioNxt Solutions has a one year low of $0.11 and a one year high of $0.57.

BioNxt Solutions (OTCMKTS:BNXTF) last announced its earnings results on Wednesday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.